Syndax Pharmaceuticals SNDX
NASDAQ SNDX
$18.24 +0.38 (+2.10%)
At close: Sep 29, 2026 · 4:00 PM EDT

Syndax Pharmaceuticals (SNDX) EBIT Margin (2015 - 2026)

Updated

Syndax Pharmaceuticals (SNDX) posted EBIT Margin of -54.95% for Q2 2026, up 127.76 percentage points from -182.71% a year earlier but down 2.22 percentage points from the prior quarter.

Analysis

Syndax Pharmaceuticals (SNDX) EBIT Margin (2015 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, EBIT Margin at Syndax Pharmaceuticals was -76.98%, up 356.71 percentage points year-over-year; for FY2025, it was -158.45%, up 1275.98 percentage points from FY2024.

  • Annual EBIT Margin shows a five-year change of +4549.73 percentage points (FY2020 to FY2025).
  • In prior years, Syndax Pharmaceuticals' EBIT Margin was -1434.43% in FY2024 and 18.77% in FY2021 (+4726.94 pp).
  • Quarterly EBIT Margin has run from a low of -2120.46% in Q2 2024 to a high of 75.65% in Q4 2021 over five years.
  • On a year-over-year basis, EBIT Margin has increased in each of the last five quarters, with an average year-over-year change of +837.17 percentage points over the last five quarters.
  • According to Business Quant data, EBIT Margin for the three prior quarters was -52.73% (Q1 2026), -91.01% (Q4 2025) and -125.19% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Margin (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 28.21%
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 37.86%
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn -3.52%
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 32.97%
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 20.57%
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 34.95%
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn -133.21%
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 28.37%
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 37.40%
10 Syndax Pharmaceuticals 1.59 Bn -137.74 Mn 69.58 Mn -54.95%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -54.95%
Mar 31, 2026 -52.73%
Dec 31, 2025 -91.01%
Sep 30, 2025 -125.19%
Jun 30, 2025 -182.71%
Mar 31, 2025 -417.91%
Dec 31, 2024 -1,254.75%
Sep 30, 2024 -716.62%
Jun 30, 2024 -2,120.46%
Dec 31, 2021 75.65%
Sep 30, 2021 -161.87%
Jun 30, 2021 -5,892.88%
Mar 31, 2021 -7,167.02%
Dec 31, 2020 -5,226.32%
Sep 30, 2020 -5,238.26%
Jun 30, 2020 -4,382.59%
Mar 31, 2020 -3,984.17%
Dec 31, 2019 -3,738.16%
Sep 30, 2019 -3,469.39%
Jun 30, 2019 -4,056.46%
API Access

Syndax Pharmaceuticals EBIT Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebit-margin&ticker=SNDX&period=max&api_key=YOUR_API_KEY